Crandon Law served as counsel to TORL BioTherapeutics, and Latham & Watkins served as counsel to Goldman, Sachs & Co. TORL BioTherapeutics LLC has announced its...
TORL BioTherapeutics’ $158 Million Series B Financing Round
Adient Global Holdings’ $1 Billion Notes Offering
Cahill represented the initial purchasers in the offering. Adient Global Holdings Ltd, a subsidiary of Adient plc, announced a Rule 144A offering of $500,000,000 aggregate principal...
BridgeBio Pharma’s $150 Million Common Stock Public Offering
Goodwin Procter advised BridgeBio Pharma on the offering, and Latham & Watkins advised the underwriters involved. BridgeBio Pharma, Inc. announced the pricing on March 7, 2023 of...
Coinbase’s Acquisition of One River Digital Asset Management
Latham & Watkins represented Coinbase in the transaction. Coinbase announced that it has acquired One River Digital Asset Management (ORDAM). ORDAM will transition to become Coinbase Asset...
Revolution Medicines’ $345 Million Common Stock Public Offering
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
TD SYNNEX’s $502 Million Secondary Offering
Pillsbury Winthrop advised TD SYNNEX, Paul Weiss advised the selling stockholders, and Davis Polk advised the lead book-running managers. TD SYNNEX Corporation announced the approximately $502...
Geron Corporation’s $198 Million Upsized Public Offering
Cooley advised Geron, while Latham & Watkins represented the underwriters in the offering. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, has announced the pricing...
Netskope’s $401 Million Investment Round
Pillsbury Winthrop Shaw Pittman LLP advised Netskope on the deal while Sidley represented Goldman Sachs Asset Management. Latham & Watkins LLP represented Morgan Stanley Tactical Value....
HYPR Corp.’s $25 Million Series C1 Financing Round
Pillsbury Winthrop Shaw Pittman advised HYPR Corp. on the deal. HYPR Corp., a New York City-based, venture-backed enterprise security software company, announced a $25 million series C1...
Blockchain Coinvestors Acquisition Corp. I’s Acquisition of Qenta
Pillsbury Winthrop Shaw Pittman LLP, Gowling WLG and Perkins Coie advised Blockchain Coinvestors Acquisition Corp. I on the deal. Blockchain Coinvestors Acquisition Corp. I (BCSA), a...
Ouster’s Merger With Velodyne
Barclays served as financial advisor and Latham & Watkins served as legal advisor to Ouster. BofA Securities, Inc. served as financial advisor and Skadden, Arps, Slate,...
Cordis’ Acquisition of MedAlliance
Latham & Watkins represented MedAlliance in the transaction. Swiss-based medical technology company MedAlliance announced it has entered into an agreement with Cordis for an acquisition which includes...